Vicore Pharma AB Statistics
NASDAQ: VCREHealth CareBiotechnology: Pharmaceutical PreparationsUSD
9.41-0.5049 (-5.09%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Vicore Pharma AB by the numbers
Vicore Pharma AB has a market capitalization of $264.9 million based on 28.16M shares outstanding. With trailing EPS of $-2.04, Vicore Pharma AB is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 3.8% below its 50-day average and 13.6% below its 200-day average.
Average daily trading volume is 23.31K shares, or about $219,195 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
VCRE valuation vs. peer median
| Metric | VCRE | Peer median | Difference |
|---|---|---|---|
| Market cap | $264.89M | $259.23M | +2% |
| Avg. volume | 23.31K | 901.53K | -97% |
Peer median across 8 companies: EBS, ALT, PRLD, GALT, RLMD, QTTB, FULC, TTRX.
Valuation
- Market cap
- $264.89M
- EPS (TTM)
- $-2.04
- Shares outstanding
- 28.16M
Price and trading
- Previous close
- 9.91
- Open
- 9.65
- Day range
- 9.41 – 10.05
- 52-week range
- 7.88 – 17.80
- Beta
- —
- Volume
- 12.97K
- Average volume
- 23.31K
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 264.89M
- Eps
- -2.04
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 17.80
- Week52 Low
- 7.88
- Avg Volume
- 23,306.00
- Shares Outstanding
- 28.16M
- Ma50
- 9.77
- Ma200
- 10.89
- Pct From52w High
- -47.16%
- Pct From52w Low
- 19.35%